Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Positive cyclin T expression as a favorable prognostic factor in treating gastric gastrointestinal stromal tumors.

Lin LF, Jin JS, Chen JC, Huang CC, Sheu JH, Chen W, Tsao TY, Hsu CW.

Mol Clin Oncol. 2016 Jun;4(6):971-975. Epub 2016 Mar 30.

2.

Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.

Jin JS, Lin LF, Chen JC, Huang CC, Sheu JH, Chen W, Tsao TY, Hsu CW.

Oncol Lett. 2015 Dec;10(6):3712-3718. Epub 2015 Sep 25.

3.

Overview of CDK9 as a target in cancer research.

Morales F, Giordano A.

Cell Cycle. 2016;15(4):519-27. doi: 10.1080/15384101.2016.1138186. Review.

4.

Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics.

Law ME, Corsino PE, Narayan S, Law BK.

Mol Pharmacol. 2015 Nov;88(5):846-52. doi: 10.1124/mol.115.099325. Epub 2015 May 27.

5.

RNA polymerase II elongation control.

Zhou Q, Li T, Price DH.

Annu Rev Biochem. 2012;81:119-43. doi: 10.1146/annurev-biochem-052610-095910. Epub 2012 Mar 9. Review.

6.

Cyclin T1 overexpression induces malignant transformation and tumor growth.

Moiola C, De Luca P, Gardner K, Vazquez E, De Siervi A.

Cell Cycle. 2010 Aug 1;9(15):3119-26. doi: 10.4161/cc.9.15.12526.

7.

Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.

Hoque M, Mathews MB, Pe'ery T.

J Cell Physiol. 2010 Apr;223(1):224-33. doi: 10.1002/jcp.22031.

8.

The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Nojima M, Huang Y, Tyagi M, Kao HY, Fujinaga K.

J Mol Biol. 2008 Oct 3;382(2):275-87. doi: 10.1016/j.jmb.2008.07.017. Epub 2008 Jul 16.

10.
12.

Supplemental Content

Support Center